Nabel Elizabeth G

Nabel Elizabeth G is listed in filings as Director at Moderna Inc. This profile follows SEC Form 4 activity through May 8, 2026, including 10 public disclosures. Recent filings connect the profile to Moderna Inc (MRNA), Medtronic Public Limited (MDT), and Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Jun 17, 2024 to May 8, 2026. Reported amounts are shown as $17.0K to $18.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.